Technical Analysis for TNYA - Tenaya Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
50 DMA Resistance | Bearish | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
BB Squeeze Ended | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
20 DMA Resistance | Bearish | -3.41% | |
MACD Bullish Signal Line Cross | Bullish | -3.41% | |
Bollinger Band Squeeze | Range Contraction | -3.41% |
Alert | Time |
---|---|
Down 2 % | about 16 hours ago |
Down 1% | about 16 hours ago |
10 DMA Support | about 21 hours ago |
20 DMA Support | about 21 hours ago |
Gap Up Closed | about 21 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was incorporated in 2016 and is based in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Gene Therapy Heart Failure Biomarkers Heart Disease Induced Stem Cells Personalized Medicine Chemical Pathology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Gene Therapy Heart Failure Biomarkers Heart Disease Induced Stem Cells Personalized Medicine Chemical Pathology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 8.09 |
52 Week Low | 1.66 |
Average Volume | 396,066 |
200-Day Moving Average | 3.67 |
50-Day Moving Average | 4.75 |
20-Day Moving Average | 4.44 |
10-Day Moving Average | 4.46 |
Average True Range | 0.31 |
RSI (14) | 41.86 |
ADX | 10.83 |
+DI | 23.42 |
-DI | 18.77 |
Chandelier Exit (Long, 3 ATRs) | 4.03 |
Chandelier Exit (Short, 3 ATRs) | 4.90 |
Upper Bollinger Bands | 4.73 |
Lower Bollinger Band | 4.14 |
Percent B (%b) | 0.19 |
BandWidth | 13.37 |
MACD Line | -0.10 |
MACD Signal Line | -0.09 |
MACD Histogram | -0.0054 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.05 | ||||
Resistance 3 (R3) | 5.13 | 4.96 | 4.91 | ||
Resistance 2 (R2) | 4.96 | 4.75 | 4.91 | 4.87 | |
Resistance 1 (R1) | 4.60 | 4.63 | 4.52 | 4.52 | 4.82 |
Pivot Point | 4.43 | 4.43 | 4.38 | 4.38 | 4.43 |
Support 1 (S1) | 4.07 | 4.22 | 3.99 | 3.99 | 3.68 |
Support 2 (S2) | 3.90 | 4.10 | 3.85 | 3.63 | |
Support 3 (S3) | 3.54 | 3.90 | 3.59 | ||
Support 4 (S4) | 3.46 |